Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Oncolytics Biotech Inc (ONCY) since 2026 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Oncolytics Biotech Inc. Table 2 shows the detailed insider transactions. This company's CIK number is 1129928.
Total stock buying since 2026: $347,585.
Total stock sales since 2026: $0.
Total stock option exercises since 2026: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2026 | 389,232 | $347,585 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2026-02 | 289,232 | $243,785 | 0 | $0 | 0 | $0 |
| 2026-01 | 100,000 | $103,800 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2026-02-12 | Hagerman Allison (VP, Product Development) | Buy | 10,000 | .83 | 8,300 |
| 2026-02-12 | Look Kirk (Chief Financial Officer) | Buy | 12,000 | .84 | 10,104 |
| 2026-02-12 | Kelly Jared (Chief Executive Officer) | Buy | 29,500 | .84 | 24,839 |
| 2026-02-12 | Brown Deborah Margaret | Buy | 25,000 | .85 | 21,250 |
| 2026-02-12 | Heineman Thomas Charles (Chief Medical Officer) | Buy | 12,132 | .83 | 10,033 |
| 2026-02-12 | Seizinger Bernd R. | Buy | 40,000 | .85 | 33,880 |
| 2026-02-12 | Pisano Wayne | Buy | 30,000 | .84 | 25,350 |
| 2026-02-12 | Andrews Patricia S | Buy | 35,400 | .86 | 30,302 |
| 2026-02-11 | Kelly Jared (Chief Executive Officer) | Buy | 5,600 | .84 | 4,681 |
| 2026-02-11 | Aromando Andrew (Chief Business Officer) | Buy | 29,600 | .86 | 25,426 |
| 2026-02-11 | Seizinger Bernd R. | Buy | 60,000 | .83 | 49,620 |
| 2026-01-16 | Seizinger Bernd R. | Buy | 100,000 | 1.04 | 103,800 |
Insider trading activities including stock purchases, stock sales, and option exercises of ONCY listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Oncolytics Biotech Inc (symbol ONCY, CIK number 1129928) see the Securities and Exchange Commission (SEC) website.